Figure 5.
Influence of compounds 6–12 on viability of Neuro-2a cells treated with 6-OHDA (a), PQ (c) and rotenone (e). Influence of compounds 6–12 on ROS level in Neuro-2a cells treated with 6-OHDA (b), PQ (d) and rotenone (f). * Differences are significant with p ≤ 0.05. ** Differences are significant with p ≤ 0.10.